Targeting innate immunity in cancer therapy
The majority of current cancer immunotherapy strategies target and potentiate antitumor
adaptive immune responses. Unfortunately, the efficacy of these treatments has been limited …
adaptive immune responses. Unfortunately, the efficacy of these treatments has been limited …
CD36-fatty acid-mediated metastasis via the bidirectional interactions of cancer cells and macrophages
Tumour heterogeneity refers to the complexity of cell subpopulations coexisting within the
tumour microenvironment (TME), such as proliferating tumour cells, tumour stromal cells and …
tumour microenvironment (TME), such as proliferating tumour cells, tumour stromal cells and …
[HTML][HTML] Crosstalk between fatty acid metabolism and tumour-associated macrophages in cancer progression
Over the last few decades, cancer has been regarded as an independent and self sustaining
progression. The earliest hallmarks of cancer comprise of sustaining proliferative signalling …
progression. The earliest hallmarks of cancer comprise of sustaining proliferative signalling …
Dawn era for revisited cancer therapy by innate immune system and immune checkpoint inhibitors
Immunotherapy is a promising therapeutic strategy for cancer. However, it shows limited
efficacy against certain tumor types. The activation of innate immunity can suppress tumors …
efficacy against certain tumor types. The activation of innate immunity can suppress tumors …
Colorectal cancer and immunity: from the wet lab to individuals
E Pramil, C Dillard, AE Escargueil - Cancers, 2021 - mdpi.com
Simple Summary Tackling the current dilemma of colorectal cancer resistance to
immunotherapy is puzzling and requires novel therapeutic strategies to emerge. However …
immunotherapy is puzzling and requires novel therapeutic strategies to emerge. However …
Exploiting tumor inflammation to increase the therapeutic impact of biguanides in oncology
S Rezzara Richard - 2024 - escholarship.mcgill.ca
Breast cancer is the most common cancer among Canadian women; 1 in 8 women are
expected to develop breast cancer in their lifetime. Breast cancer is grouped into four distinct …
expected to develop breast cancer in their lifetime. Breast cancer is grouped into four distinct …
[PDF][PDF] Interleukin-27 Disrupts the Crosstalk of Apoptotic Activities between 4T1 Breast Cancer Cells and M2 Macrophages
NM Yusof, NNMN Fuadi, M Hamid… - Malaysian Journal of …, 2022 - medic.upm.edu.my
Introduction: Cytokine immunotherapy such as Interleukin-27 (IL-27) has been foreseen as a
promising alternative anti-cancer treatment. Thus, this study aimed to investigate whether IL …
promising alternative anti-cancer treatment. Thus, this study aimed to investigate whether IL …
[PDF][PDF] Targeting Innate Immunity in Cancer Therapy. Vaccines 2021, 9, 138
S Rameshbabu, BW Labadie, A Argulian, A Patnaik - 2021 - pdfs.semanticscholar.org
The majority of current cancer immunotherapy strategies target and potentiate antitumor
adaptive immune responses. Unfortunately, the efficacy of these treatments has been limited …
adaptive immune responses. Unfortunately, the efficacy of these treatments has been limited …